Cardiovascular Magnetic Resonance Scan Repeatability in ST Segment Elevation Myocardial Infarction

University of Bristol1 site in 1 country40 target enrollmentNovember 2011

ConditionsSTEMI

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: STEMI
Sponsor: University of Bristol
Enrollment: 40
Locations: 1
Primary Endpoint: Inter-observer, intra-observer and inter-scan variability and agreement
Status: Completed
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The investigators propose to conduct a study to measure the reproducibility of CMR parameters that have been used to predict outcome following PPCI: infarct size, left ventricular volumes, myocardial salvage, microvascular obstruction (MVO) and myocardial oedema.

Registry

clinicaltrials.gov

Start Date

November 2011

End Date

April 2013

Last Updated

11 years ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

University of Bristol

Responsible Party

Principal Investigator

Elisa McAlindon

Cardiology Clinical Research Fellow

University of Bristol

Eligibility Criteria

Inclusion Criteria

•Participant may enter study if ALL of the following apply
•ST segment myocardial infarction as defined by ECG (by 2 contiguous limb leads with \>1 mm ST-segment elevation, or \>2 mm ST-segment elevation in contiguous precordial leads, or new LBBB) and \> 20 minutes of cardiac chest pain
•Written informed consent

Exclusion Criteria

•Participant may not enter study if ANY of the following apply
•Contraindication to MRI (implanted pacemaker/ defibrillator, ferromagnetic metal implant/ injury, claustrophobia, obesity/ too large for CMR scanner)
•Known allergy to gadolinium
•Chronic atrial fibrillation
•Renal impairment with eGFR \<30
•Cardiogenic shock
•Patients with special communication needs